NCT06359600View on ClinicalTrials.gov

A Study of HS-10501 Tablets in Healthy Subjects

PHASE1RecruitingINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

March 14, 2024

Primary Completion Date

January 31, 2025

Study Completion Date

June 30, 2025

Conditions
Healthy Subjects
Interventions
DRUG

HS-10501 tablet

Administered orally

DRUG

Placebo

Administered orally

Trial Locations (1)

230601

RECRUITING

The second hospital of Anhui University, Hefei

Sponsors
All Listed Sponsors
lead

Jiangsu Hansoh Pharmaceutical Co., Ltd.

INDUSTRY